Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort pMDI vs Formoterol Turbuhaler in COPD (RISE)
NCT02157935Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jun 2014; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02157935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157935.